Search

Your search keyword '"A. Ballaz"' showing total 963 results

Search Constraints

Start Over You searched for: Author "A. Ballaz" Remove constraint Author: "A. Ballaz"
963 results on '"A. Ballaz"'

Search Results

1. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

2. Improving diabetic retinopathy screening using Artificial Intelligence: design, evaluation and before-and-after study of a custom development

3. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

6. Red cell distribution width-to-platelet ratio (RPR) as a predictor of prolonged stay at hospital for COVID-19 inpatients

7. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

8. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

10. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

11. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

15. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

16. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

17. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

19. Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study

21. Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired Pneumonia

23. Genotoxic and neurotoxic potential of intracellular nanoplastics: A review.

24. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

25. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

27. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

29. Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis

31. Timing and characteristics of venous thromboembolism after noncancer surgery

32. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

33. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

36. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

37. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

39. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

44. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

45. Sex-Dependent Performance of the Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte and Mean Platelet Volume-to-Platelet Ratios in Discriminating COVID-19 Severity

Catalog

Books, media, physical & digital resources